Pharmacology
Latest News
Physicians urged to write indications on drug scripts as methotrexate users face new barriers with SCOTUS decision
Prior to the Supreme Court’s ruling, physicians were concerned about the impact an overturning of the 1973 law would have on patient access to MTX...
News
New KRAS inhibitor shows promise in NSCLC
One out of three lung cancer patients previously treated with chemotherapy and immune therapy responded to a new targeted therapy.
Latest News
FDA approves combination pegloticase and methotrexate for refractory gout
In the phase 4 trial, co-administration of pegloticase and methotrexate reduced the formation of new anti-PEG antibodies.
Commentary
Drugging the undruggable
Targeted therapies are the ideal in drug development. New drugs that target KRAS (G12C) mutations mark a significant leap forward in oncology.
News
U.S. allows pharmacists to prescribe Paxlovid directly
“Since Paxlovid must be taken within 5 days after symptoms begin, authorizing state-licensed pharmacists to prescribe Paxlovid could expand access...
News
When too much treatment creates more harm than good
Some aggressive end-of-life care is associated with lower quality of life for patients, poorer bereavement for families.
News
How to manage cancer pain when patients misuse opioids
“Opioid use disorder is a really important factor in quality of life, so addressing opioid addiction and prescription opioid misuse in people with...
News
Head and neck tumor grade may predict response to immunotherapy
Small study shows that high-grade head and neck tumors, not low grade, may be better suited for immunotherapy.
Latest News
Experimental cancer drug promising for hospitalized COVID patients
The manufacturer is seeking emergency use authorization from the Food and Drug Administration.
News
What explains poor adherence to eosinophilic esophagitis therapy?
Among patients with eosinophilic esophagitis, less than half complied with long-term medical or dietary therapy, according to a new study.